Infectious Diseases

Virtual Reference Site Visit: Taipei Veterans General Hospital (RED 2021)

Virtual Reference Site Visit: Taipei Veterans General Hospital

Taipei Veterans General Hospital (VGH-TPE) is a national first-class medical centre in Taiwan with the ambition to impact the healthcare industry by leveraging innovation. This session will focus on how VGH-TPE (a) introduces new technology solutions to improve patient experience; (b) changes the way of disease management for better patient outcome; and (iii) embrace new […]

Virtual Reference Site Visit: Taipei Veterans General Hospital (RED 2021) Read More »

Reforming Indian healthcare in the post-COVID era: insights from Dr Indu Bhushan (RED 2021)

Reforming Indian healthcare in the post-COVID era: insights from Dr Indu Bhushan (RED 2021)

As India emerges from the shadow of the COVID-19 pandemic, it has major opportunities to reform its public health system. This presentation by Dr Indu Bhushan, a Senior Associate in the School of Public Health at Johns Hopkins University, India, highlights the key gaps that need to be filled and top priorities that should be

Reforming Indian healthcare in the post-COVID era: insights from Dr Indu Bhushan (RED 2021) Read More »

COVID-19, lab diagnostics and health policy in Asia Pacific: insights from Dr Swee Kheng Khor (RED 2021)

COVID-19, lab diagnostics and health policy in Asia Pacific: insights from Dr Swee Kheng Khor (RED 2021)

The COVID-19 pandemic has demonstrated the enduring importance of diagnostics and brought clinical lab leaders in closer contact with health policymakers than ever before. This talk by Dr Swee Kheng Khor, a global health expert with deep experience in the Asia Pacific region, explores key considerations for the clinical lab community to make the most

COVID-19, lab diagnostics and health policy in Asia Pacific: insights from Dr Swee Kheng Khor (RED 2021) Read More »

Life after COVID: disease management and diagnostics in the post-pandemic era (RED 2021)

Life after COVID: disease management and diagnostics in the post-pandemic era (RED 2021)

For the past two years, healthcare systems everywhere were preoccupied with COVID-19 management, but as we gradually recalibrate to a new normal, questions arise about what the future will hold. What is the role of hospitals and clinical labs in a world where COVID-19 is endemic? How will we simultaneously meet the growing challenges of

Life after COVID: disease management and diagnostics in the post-pandemic era (RED 2021) Read More »

Measurement of direct oral anticoagulants (DOACs) and contact pathway inhibitors

Measurement of Direct Oral Anticoagulants and Contact Pathway Inhibitors

At the Roche Diagnostics-sponsored satellite symposium ‘From Basic Research to Clinical Data: the Future of Patient Management’ hosted during the International Society for Haemostasis (ISTH) 2021 congress, Prof. Jonathan Douxfils discussed the value of monitoring direct oral anticoagulants (DOAC) and contact pathway inhibitors. While DOACs were developed without the need for routine laboratory monitoring, the

Measurement of direct oral anticoagulants (DOACs) and contact pathway inhibitors Read More »

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming

Liver disease is a serious public health issue in Taiwan. In a population of over 23 million, roughly 15%–20% of adults are hepatitis B viral (HBV) carriers, and 2%–5% are infected with hepatitis C virus (HCV) [1]. To address these challenges, Taiwan’s healthcare community has shown a strong commitment to fighting viral hepatitis, improving outcomes

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming Read More »

In a world without COVID data standards, a digital health ecosystem emerges

In a world without COVID data standards, a digital health ecosystem thrives

We’re still at the point in this pandemic where talking about opening-up feels a bit premature—tempting fate, as it were. But it’s not only the virus that could be holding things up: there’s also the lack of agreement on global standards to record, share and verify data about an individual’s health status that would accompany

In a world without COVID data standards, a digital health ecosystem emerges Read More »

COVID-19 and antithrombotics: What we know now

covid and antithrombotics

At the Roche Diagnostics-sponsored satellite symposium ‘From Basic Research to Clinical Data: the Future of Patient Management’ hosted during the International Society for Haemostasis (ISTH) 2021 congress, Dr Jean M Connors MD gave an insightful presentation on thrombo-inflammation in the COVID-19 era. The disease COVID-19 has been identified as a hypercoagulable state. The development of

COVID-19 and antithrombotics: What we know now Read More »

Four ways the global coagulation community responded to the COVID-19 pandemic

101283112_m

Since the onset of the COVID-19 pandemic, mounting evidence has shown that patients with severe infection are more likely to have COVID-associated coagulopathies. The global coagulation community responded rapidly with various societies reviewing available data and providing recommendations and educational resources [1]. Researchers also spearheaded a multi-platform randomised trial to support the community to make

Four ways the global coagulation community responded to the COVID-19 pandemic Read More »

Scroll to Top